Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia

Ravi Savarirayan

Murdoch Children’s Research Institute, Melbourne, VIC, Australia

Julie Hoover-Fong

Johns Hopkins University, Baltimore

Melita Irving

Guy’s and St. Thomas’ NHS Foundation Trust, London

Paul Arundel

Sheffield Children’s NHS Foundation Trust, Sheffield, United Kingdom

Josep Maria de Bergua

Arthroscopic Surgery Unit, Medical Innovation Knowledge Sharing Hospital, Vitoria-Gasteiz, Spain

Philippe M. Campeau

Toby Candler

University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

Benjamin T. Cocanougher

Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati

Valérie Cormier-Daire

Thomas Edouard

Endocrine, Bone Diseases, and Genetics Unit, Reference Center for Rare Diseases of Calcium and Phosphate Metabolism, Pediatric Research Unit Centre d’Investigation Clinique 1436, Children’s Hospital, Toulouse University Hospital, Toulouse, France

Svein O. Fredwall

Oslo University Hospital, Oslo

Paul Harmatz

UCSF Benioff Children’s Hospital Oakland, Oakland, CA

Daniel Hoernschemeyer

University of Missouri, Columbia

Henrik U. Irgens

Haukeland University Hospital, Bergen, Norway

Saumya Jamuar

KK Women’s and Children’s Hospital, Singapore

Peter Kannu

University of Alberta–Stollery Children’s Hospital, Edmonton, Canada

Janet M. Legare

University of Wisconsin School of Medicine and Public Health, Madison

Antonio Leiva-Gea

Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, Plataforma Bionand, Hospital Quironsalud Málaga, and Department of Biomedicine, Faculty of Biomedical Sciences and Sports, Universidad Europea de Andalucía, Malaga, Spain

Helen McDevitt

NHS Greater Glasgow and Clyde, Glasgow, United Kingdom

Roberta Onesimo

Università Cattolica del Sacro Cuore–Fondazione Policlinico A. Gemelli IRCCS, Rome

John Phillips

Vanderbilt Health, Nashville

Mariana del Pino

Hospital de Pediatría Garrahan, Buenos Aires

Marie-Eve Robinson

Children’s Hospital of Eastern Ontario, University of Ottawa, Ottawa

Massimiliano Rossi

Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France

Mars Skae

Manchester University NHS Foundation Trust and University of Manchester, Manchester, United Kingdom

Leanne M. Ward

Children’s Hospital at London Health Sciences Centre, London, ON, Canada

Klane K. White

Children’s Hospital of Colorado, Aurora

Jane Schmidt

BridgeBio Pharma, San Francisco

Ted Lystig

BridgeBio Pharma, San Francisco

Ariana Salvatici

BridgeBio Pharma, San Francisco

Yun Bai

Institute of Energy Materials Science (IEMS)

Peter W. Butler

BridgeBio Pharma, San Francisco

David van Veenhuyzen

BridgeBio Pharma, San Francisco

Daniela Rogoff

BridgeBio Pharma, San Francisco